Amanda Kreienheder I, Clinical Nurse Specialist - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3315 8th St, Lewiston, ID 83501 Phone: 208-743-9543 |
Mrs. Esther Spataro, AGNP-C Clinical Nurse Specialist - Gerontology Medicare: Medicare Enrolled Practice Location: 415 6th St, Lewiston, ID 83501 Phone: 208-799-5540 |
Judy A Metelko, CNS,ARNP Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 415 6th St, Lewiston, ID 83501 Phone: 208-743-2511 Fax: 208-799-5554 |
News Archive
Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it was included in a report of President Obama's Council of Advisors on Science and Technology entitled "Report to the President on Reengineering the Influenza Vaccine Production Enterprise to Meet the Challenges of Pandemic Influenza", which was released earlier this month. U.S. Health and Human Services Secretary Kathleen Sebelius and other public health officials held a briefing to discuss this report and the $2 billion plan to accelerate the development of drugs and vaccines to prevent the spread of infectious diseases.
Excluding deer could be a counterproductive strategy for controlling tick-borne infections, because the absence of deer from small areas may lead to an increase in ticks, rapidly turning the area into a potential disease hotspot, according to a team of U.S. and Italian researchers.
HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.
St. Jude Children's Research Hospital scientists have identified a protein that certain high-risk acute lymphoblastic leukemia (ALL) cells need to survive and have used that knowledge to fashion a more effective method of killing tumor cells. The findings appear in the August 29 edition of the journal Blood.
Since the start of the novel coronavirus outbreak, now officially called coronavirus disease (COVID-19), surgical mask prices have skyrocketed as panic ensues around the globe. Retail giant Amazon has warned against sellers marking up their prices, while Facebook has announced measures against misleading coronavirus adverts and information.
› Verified 1 days ago